Inventor · disambiguated record
Piers Ingram
Also filed as: INGRAM PIERS
6 granted patents·17 pending applications·21 citations·filing 2018–2024
77Inventor score
Files withHUMMINGBIRD BIOSCIENCE PTE LTD15HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD7HUMMINGBIRD BIOSCIENCES HOLDINGS LTD1
Top patents by PatentIndex Score
23 records- 0191US10633456B1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Granted Apr 28, 2020·14 cites·25 claims
- 0289US10662241B1HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Granted May 26, 2020·6 cites·25 claims
- 0383US2025019461A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2024·Application pending·0 cites
- 0481US11208498B2Treatment and prevention of cancer using HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2021·Granted Dec 28, 2021·1 cites·16 claims
- 0580US2024092937A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2023·Application pending·0 cites
- 0676US2024158538A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2023·Application pending·0 cites
- 0767US11780933B2HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2020·Granted Oct 10, 2023·0 cites·13 claims
- 0867US2021024651A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
- 0965US11685789B2CD47 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Granted Jun 27, 2023·0 cites·11 claims
- 1064US2019300624A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2018·Application pending·0 cites
- 1163US2021380697A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
- 1260US2019300610A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2018·Application pending·0 cites
- 1358US11873346B2VISTA antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2020·Granted Jan 16, 2024·0 cites·13 claims
- 1458US2022153870A1Treatment and prevention of cancer using her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCES HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 1556US2024238439A1Her3-binding antibody-drug conjugateHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2024·Application pending·0 cites
- 1655US2025313631A1Treatment and prevention of cancer using vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Application pending·0 cites
- 1755US2025136712A1Treatment and prevention of cancer using her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Application pending·0 cites
- 1854US2024279340A1Cells expressing vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Application pending·0 cites
- 1953US2024270871A1Cells expressing her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Application pending·0 cites
- 2053US2025122303A1Treatment and prevention of cancer using her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Application pending·0 cites
- 2150US2023374147A1Bcma/taci antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2021·Application pending·0 cites
- 2250US2022298254A1Cd47 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2018·Application pending·0 cites
- 2349US2021388083A1Engineered fcHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Piers Ingram files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →